WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 8 fonti

El dueño de Kleenex compra la empresa de Tylenol y Neutrógena por casi 35.000 millones

Kimberly-Clark se hace con Kenvue, con marcas como Johnson’s o Listerine, una empresa a la que Trump acusa de vender un analgésico relacionado con el autismo

Raccontata dacnbc.comansa.itusatoday.comforbes.comupi.combbc.comelpais.comaljazeera.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
elpais.comStai leggendo8 mesi fa

El dueño de Kleenex compra la empresa de Tylenol y Neutrógena por casi 35.000 millones

Kimberly-Clark se hace con Kenvue, con marcas como Johnson’s o Listerine, una empresa a la que Trump acusa de vender un analgésico relacionado con el autismo

originale
ansa.it8 mesi fa

Kimberly-Clark acquista produttore Kenvue per 40 miliardi - Ultima ora - Ansa.it

Kimberly-Clark, il colosso a cui fanno capo i Kleenex e gli Huggies, ha raggiunto un accordo per acquistare Kenvue, la società che produce il Tylenol, per 40 miliardi di dollari. (ANSA)

Leggi questa versione → originale
bbc.com8 mesi fa

Kimberly-Clark buys Tylenol-maker Kenvue in more than $40bn deal

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

Leggi questa versione → originale
cnbc.com8 mesi fa

Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.

Leggi questa versione → originale
forbes.com8 mesi fa

Huggies Maker Buys Kenvue (Tylenol Maker) For $48 Billion

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

Leggi questa versione → originale
aljazeera.com8 mesi fa

Kimberly-Clark to buy Tylenol maker Kenvue for $40bn

The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 3 novembre 2025·cnbc.com

    Kimberly-Clark to buy Kenvue in $48.7 billion deal

    Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.

  2. lunedì 3 novembre 2025·cnbc.com

    Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

    The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.

  3. lunedì 3 novembre 2025·ansa.it

    Kimberly-Clark acquista produttore Kenvue per 40 miliardi - Ultima ora - Ansa.it

    Kimberly-Clark, il colosso a cui fanno capo i Kleenex e gli Huggies, ha raggiunto un accordo per acquistare Kenvue, la società che produce il Tylenol, per 40 miliardi di dollari.…

  4. lunedì 3 novembre 2025·ansa.it

    Kimberly-Clark acquista produttore Kenvue per 40 miliardi - Notizie - Ansa.it

    Kimberly-Clark, il colosso a cui fanno capo i Kleenex e gli Huggies, ha raggiunto un accordo per acquistare Kenvue, la società che produce il Tylenol, per 40 miliardi di dollari.…

  5. lunedì 3 novembre 2025·usatoday.com

    Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal

    Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to autism.

  6. lunedì 3 novembre 2025·forbes.com

    Huggies Maker Buys Kenvue (Tylenol Maker) For $48 Billion

    President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

  7. lunedì 3 novembre 2025·upi.com

    Kimberly-Clark agrees to purchase Kenvue for $48.7B - UPI.com

    The Texas-based Kimberly-Clark Corporation announced Monday it reached a deal to purchase Kenvue for $48.7 billion.

  8. lunedì 3 novembre 2025·bbc.com

    Kimberly-Clark buys Tylenol-maker Kenvue in more than $40bn deal

    The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

  9. lunedì 3 novembre 2025·elpais.com

    El dueño de Kleenex compra la empresa de Tylenol y Neutrógena por casi 35.000 millones

    Kimberly-Clark se hace con Kenvue, con marcas como Johnson’s o Listerine, una empresa a la que Trump acusa de vender un analgésico relacionado con el autismo

  10. lunedì 3 novembre 2025·aljazeera.com

    Kimberly-Clark to buy Tylenol maker Kenvue for $40bn

    The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.

  11. martedì 4 novembre 2025·cnbc.com

    Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

    Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.